First National Bank of Omaha’s Quest Diagnostics DGX Stock Holding History

First National Bank of Omaha’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.54M	Sell	35,533 -25,161	-41%	-$4.94M	0.21%	113
2026 Q1	$11.9M	Buy	60,694 +495	+0.8%	+$96.2K	0.37%	68
2025 Q4	$10.5M	Buy	60,199 +13,867	+30%	+$2.53M	0.31%	76
2025 Q3	$8.83M	Buy	46,332 +10,813	+30%	+$1.92M	0.56%	48
2025 Q2	$6.38M	Buy	+35,519	New	+$6.17M	0.41%	67

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

First National Bank of Omaha's DGX Position: Q2 2026 in Review

First National Bank of Omaha reduced its Quest Diagnostics (DGX) stake by 41% in Q2 2026, selling an estimated $4.94M and leaving 35,533 shares worth $7.54M. The position accounts for 0.21% of the portfolio, ranked #113.

First National Bank of Omaha first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. The position peaked at $11.9M in Q1 2026. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

First National Bank of Omaha held 35,533 shares of Quest Diagnostics worth $7.54M as of Q2 2026.
First National Bank of Omaha sold 25,161 Quest Diagnostics shares in Q2 2026, an estimated $4.94M.
Quest Diagnostics made up 0.21% of First National Bank of Omaha's portfolio in Q2 2026, its #113 holding.
First National Bank of Omaha first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
First National Bank of Omaha's Quest Diagnostics position peaked at $11.9M in Q1 2026.
629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on First National Bank of Omaha's 13F filing for Q2 2026, filed 7 Aug 2026.